Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodiol in Barrett's Esophagus
NCT01097304Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2010
- Primary completion
- Apr 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ursodeoxycholic acid in Barrett's esophagus, esophageal carcinoma, sponsored by National Cancer Institute. Started Apr 2010; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
Barrett's esophagusesophageal carcinoma
Beyond the preview
Go deeper on NCT01097304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01097304.